Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats

Abstract

BACKGROUND Alendronate (ALN) is the most common form of bisphosphonates used for the treatment of osteoporosis. Osteoprotegerin (OPG) has also been shown to reduce osteoporotic changes in both humans and experimental animals after systemic administration. The aim of this current study was to test if the anti-resorption effects of ALN may be enhanced when… (More)
DOI: 10.1186/1749-799X-6-34

Topics

8 Figures and Tables

Cite this paper

@inproceedings{Wang2011AlendronateC, title={Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats}, author={Yan Wang and Peng Huang and P. S. Tang and Kai-Ming Chan and G. R. Li}, booktitle={Journal of orthopaedic surgery and research}, year={2011} }